Grifols Diagnostic Solutions Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingEmeryville, CA
Founded
2014
Primary NAICS
325413
CAGE code
7AJ96
Federal awards
$6.1M
Overview
Explore Grifols' comprehensive, innovative and patient-centric biopharma and healthcare solutions.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Analytical Laboratory Instrument ManufacturingOther Commercial and Industrial Machinery and Equipment Rental and LeasingMedical LaboratoriesIn Vitro Diagnostic Substances, Reagents, Test Kits and SetsLaboratory Equipment and Supplies
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $539,880 | 18 |
| 2026 | Department of Defense | $518,777 | 3 |
| 2025 | Department of Defense | $762,540 | 10 |
| 2025 | Department of Veterans Affairs | $512,467 | 32 |
| 2024 | Department of Defense | $763,740 | 8 |
| 2024 | Department of Veterans Affairs | $249,139 | 16 |
| 2024 | Department of Health and Human Services | -$0 | 1 |
| 2023 | Department of Defense | $762,540 | 6 |
| 2023 | Department of Veterans Affairs | $620,935 | 26 |
| 2023 | Department of Health and Human Services | -$14,518 | 1 |
| 2022 | Department of Defense | $762,540 | 12 |
| 2022 | Department of Veterans Affairs | $610,364 | 23 |